The China Cancer Biomarkers market was valued at USD 1,100.00 Million in 2023 and is expected to reach USD 4,100.00 Million by 2031, growing at a CAGR of 18% (2024-2031). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.
The Cancer Biomarkers market was valued at USD 13.24 Billion in 2022 and is expected to reach USD 36.74 Billion by 2030, growing at a CAGR of 13.6% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.